홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.1
  1. 홈
  2. /반응

Cesium carbonate → 2-methyl-1-[4-(3-quinolin-6-ylmethyl-3H-[1,2,3]triazolo[4,5-b]pyrazin-5-yl)-pyrazol-1-yl]-propan-2-ol

HRID 15995
인쇄

반응식

HRID 15995 반응식
[NH:1]1[CH:5]=[C:4]([C:6]2[N:11]=[C:10]3[N:12]([CH2:15][C:16]4[CH:17]=[C:18]5[C:23](=[CH:24][CH:25]=4)[N:22]=[CH:21][CH:20]=[CH:19]5)[N:13]=[N:14][C:9]3=[N:8][CH:7]=2)[CH:3]=[N:2]1.C([O-])([O-])=O.[Cs+].[Cs+].[CH3:32][C:33]1([CH3:36])[CH2:35][O:34]1>CN(C=O)C>[CH3:32][C:33]([OH:34])([CH3:36])[CH2:35][N:2]1[CH:3]=[C:4]([C:6]2[N:11]=[C:10]3[N:12]([CH2:15][C:16]4[CH:17]=[C:18]5[C:23](=[CH:24][CH:25]=4)[N:22]=[CH:21][CH:20]=[CH:19]5)[N:13]=[N:14][C:9]3=[N:8][CH:7]=2)[CH:5]=[N:1]1
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 10796Cesium carbonateHCID 11208Isobutylene oxideHCID 248519536-[6-(1H-pyrazol-4-yl)-[1,2,3]triazolo[4,5-b]pyrazin-1-ylmethyl]-quinoline

생성물 1

HCID 593418452-methyl-1-[4-(3-quinolin-6-ylmethyl-3H-[1,2,3]triazolo[4,5-b]pyrazin-5-yl)-pyrazol-1-yl]-propan-2-ol수율 22%

시약·촉매·용매 1

HCID 6228Dimethylformamide
용매

반응 조건

온도
80 °C

실험 절차

To a suspension of 6-[6-(1H-pyrazol-4-yl)-[1,2,3]triazolo[4,5-b]pyrazin-1-ylmethyl]-quinoline (50 mg, 0.15 mmol) and Cs2CO3 (50 mg, 0.15 mmol) in DMF (2 mL) was added 2,2-dimethyl-oxirane. The reaction was stirred at 80° C. for 16 hours. The reaction was then purified with a reverse-phased preparative HPLC eluting with acetonitrile-water having 0.1% acetic acid to yield 2-methyl-1-[4-(3-quinolin-6-ylmethyl-3H-[1,2,3]triazolo[4,5-b]pyrazin-5-yl)-pyrazol-1-yl]-propan-2-ol (13 mg, 22% yield).

후처리

  1. customThe reaction was then purified with a reverse-phased preparative HPLC
  2. washeluting with acetonitrile-water having 0.1% acetic acid

출처 및 근거

ORD 기록
ord-fdda75a4549845cc8f7d28aa5e280eb8
출처 데이터셋
uspto-grants-2010_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07732604B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트